<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet><Article><Journal><PublisherName></PublisherName><JournalTitle>Knowledge &amp; Health Journal</JournalTitle><Issn>1735-577X</Issn><Volume>3</Volume><Issue>2</Issue><PubDate PubStatus="epublish"><Year>2008</Year><Month>09</Month><Day>15</Day></PubDate></Journal><VernacularTitle>Relationship between the Dose of Erythropoietin and the Dialysis Adequecy</VernacularTitle><FirstPage>7</FirstPage><LastPage>12</LastPage><ELocationID EIdType="doi">10.1234/knh.v3i2.208</ELocationID><Language>FA</Language><AuthorList><Author><FirstName>Hossein</FirstName><LastName>Ebrahimi</LastName><Affiliation>دانشگاه علوم پزشکی شاهرود- گروه پرستاری.. h-ebrahimi@yahoo.com</Affiliation></Author><Author><FirstName>Ahmad</FirstName><LastName>Khosravi</LastName></Author><Author><FirstName>Nahid</FirstName><LastName>Bolbolhaghighi</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2013</Year><Month>08</Month><Day>21</Day></PubDate></History><Abstract>Introduction: The aim of the present study was to examine the relationship between the dose of recombinant human erythropoietin (EPO) and the dialysis efficacy in shahroud hemodialysis patients.Methods: After the inclusion of subjects with atleast 6 months history of dialysis, therapy requirements of subcutaneus EPO for 4 months, frettin&amp;gt;100 ng/ml and target hematocrite to 30%, data from 54 hemodialysis patients in shahroud were collected. Dialysis adequecy was evaluated with Kt/V index.Results: Thirty males (55.6%) and 24 females (44.4%) were evaluated that in 38 patients (70.4%) equilibrated Kt/V was less than 1.2 (low adequecy) and 29.6% (16 patients) have equilibrated Kt/V over 1.2. Frettin, iron, Hb and HCT levels did not differ between the 2 groups, but in patients with Kt/V&amp;gt;1.2 the mean injected EPO dose was significantly less than the other group.Conclusion: Compared with other study we identified that adequate dialysis (Kt/V&amp;gt;1.2) can reduces the need to EPO doses and also can to decrease its costs and side effects.</Abstract></Article></ArticleSet>
